Oxygen Toxicity: Why Can't a Human Be More Like a Turtle?
In this issue of the journal Jenkinson provides an authoritative, current review on oxygen toxicity [1] . ], He amply portrays &dquo;therapeutic&dquo; hyperoxia as a potential villain that may fire &dquo;free radical&dquo; bullets at an unsuspecting recipient of ventilator care. He clearly states the mechanism by which hyperoxia produces tissue injury and adequately discusses the potential protective mechanisms against this injury.
To put the subject into perspective, it is important to remember that it is indeed the intubated, ventilated patient who is most at risk for encountering exposure to hyperoxia at a level that may produce lung injury. There is no evidence that the degree of alveolar hyperoxia produced by conventional home oxygen delivery systems, or even short-duration use of non-rebreathing oxygen masks, can produce sustained injury to the lung.
Similarly, the duration of safe exposure to hyperbaric oxygen is well known, and damaging exposures are routinely avoided in this setting. These comments immediately raise the question, &dquo;What is a safe level of oxygen concentration to use for a patient on a ventilator?&dquo; This is not an easy question to answer because many variables may enter into the analysis. Animal experiments indicate that younger members of a species are more resistant to oxygen toxicity than older ones; thus, age appears to be one factor in the development of toxicity.
Furthermore, metabolic rate has a role. The febrile or hyperthyroid patient is more susceptible to injury than the hypothermic or hypothyroid one. Certain drugs or chemicals that produce oxygen-free radicals enhance oxygen toxicity. Thus, the patient with paraquat poisoning may receive an additional dose of free radicals with exposure to hyperoxia. Certain dietary deficiencies discussed by Jenkinson enhance the toxic effects of hyperoxia. It is not known how underlying pulmonary disease itself may influence oxygen toxicity. Although lung disease may create large alveolar-arterial oxygen gradients, thereby potentially protecting certain areas of lung, it is also accompanied by neutrophils that may enhance the generation of free radicals.
Whether the same concentrations of oxygen administered at sea level and at altitude are equally injurious is unsettled. Many hypothetical considerations are involved in assessing the oxygen level that is likely to injure tissue. For want of better guidelines, it may be reasonable to assume that oxygen concentrations greater than 80% likely produce considerable tissue injury within 36 to 48 hours. Concentrations between 60 and 80% are also likely to produce injury but at a slower rate. Levels less than 50 to 60% are probably safe for prolonged intervals in the absence of other predisposing factors to injury.
These guidelines may, of course, require adjustment as more information becomes available.
Next, the issue of which body tissue is likely to be injured by hyperoxia should be addressed. The tissue most prone to injury under atmospheric conditions is the lung because it is exposed to the highest partial pressure of oxygen. The pulmonary vascular endothelium is particularly prone to injury, and any small injury to this fragile barrier may be manifested as pulmonary edema. Seizure disorders resulting from hyperoxia occur only with hyperbaric exposure and are probably related to alteration in threshold of the action potential of neurological tissue before damage to other tissue such as the lung is manifested. A curious feature of oxygen toxicity is that manifestations of lung injury are delayed rather than immediate, indicating a good initial defense system before damage by oxygen-free radicals takes place. Despite this, events occurring soon after exposure to hyperoxia (within the first few hours) are critical for determining later events of the injury [2] . Neonatal retrolental fibroplasia caused by exposure to hyperoxia seems to be related to exposure at a critical developmental period because it does not occur later in life. Similarly, it is not known if there is anything unique about neonatal bronchopulmonary dysplasia to distinguish it from lung damage resulting from hyperoxia in the adult. Does exposure to hyperoxia damage other tis-sues besides the lung, eye, and nervous system? This question has not been clearly answered, although it has been suggested that other organs may be damaged as well. The question has bearing on Jenkinson's comments that hyperoxia exposure may depress cardiac output and erythropoiesis and elevate systemic resistance (see Jenkinson's Table   1 ). I am not convinced that these physiological events have yet been proven to be manifestations of toxicity from exposure to hyperoxia.
How closely does the animal model of oxygen toxicity correspond to events occurring in humans? As noted by Jenkinson, some approximations regarding the pathophysiology of oxygen toxicity in humans have been made from short-term exposures to normal subjects, from physiological measurements in brain-injured patients, and from autopsy examination of tissue. In humans these assessments are often difficult because ethical considerations prevent complete studies, and other variables are always present. There is no question about oxygen being a toxic substance for both plant and animal life (Pasteur noted this over 100 years ago [3] ). There is variability among species, however, and this must be considered when applying the results of animal data to humans. The turtle would have no problem being ventilated in the intensive care unit because it is known to live for weeks or even months in a hyperoxic environment [4] . The rat is unique in its response to endotoxin plus hyperoxia: It accelerates the production of protective enzymes [5] . Other species fail to do so, however, and endotoxin is more injurious to them. Although we have been highly dependent upon species other than humans for invaluable data to unravel the mysteries of oxygen toxicity, studies of other species must be approached with caution when applying them to events in the critical care unit. Whether current studies of primates will provide a closer approximation to the human situation remains to be determined. Nevertheless, these considerations may only fine-tune information and be unimportant in assessing factors that protect or potentiate oxygen toxicity. It may be very difficult to conduct an adequately controlled study to evaluate the effectiveness of protective agents against oxygen toxicity in the critical care unit, and animal studies may be our only recourse.
In the final analysis, if we could safely and effectively protect against oxygen toxicity, we could use oxygen therapy with impunity in the critical care unit. Such an approach would alleviate consideration of other therapeutic modalities such as extracorporeal circulation for patients with lung disease who require temporary high levels of oxygen. Several potential strategies that may address this problem are on the horizon. Methods to stimulate endogenous protective enzymes and other substances such as superoxide dismutase, catalase, and glutathione are available but may cause lung injury. For example, stimulation can be achieved by exposure to relatively low levels of hyperoxia or with compounds such as endotoxin combined with oxygen (at least in the rat), but injury by these approaches is still a deterrent to their use. Frank [6] addressed this issue experimentally with the use of noninjurious modifications of endotoxin and
